Omega 3 Fatty Acid: US vs China

Market size, growth to 2033 and clinical trials, side by side.

The US is the bigger Omega 3 Fatty Acid market: $1.7 Bn against $330 Mn in 2023, about 5.2 times as large.

China grows faster: 8.9% a year, against 5.4%. The gap still grows from $1.4 Bn to $2.1 Bn by 2033.

Clinical research: 133 active trials in the US, 30 in China.

Omega 3 Fatty Acid: US compared with China
Measure US China
Market size, 2023$1.7 Bn$330 Mn
Market size, 2033 projected$2.9 Bn$773 Mn
Growth a year (CAGR)5.4%8.9%
Money added, 2023–2033$1.2 Bn$444 Mn
Share of the world market42%8%
Size rank of 24 countries#1#2
Market per person, 2023$5.04$0.23
Active clinical trials 133 30
Full reportUS report China report

Year by year, 2023 to 2033

US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.

Quick answers

Which is bigger in Omega 3 Fatty Acid, US or China?

The US is the bigger Omega 3 Fatty Acid market: $1.7 Bn against $330 Mn in 2023, about 5.2 times as large.

Which grows faster in Omega 3 Fatty Acid, US or China?

China grows faster: 8.9% a year, against 5.4%. The gap still grows from $1.4 Bn to $2.1 Bn by 2033.

More Omega 3 Fatty Acid comparisons

Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.